Back
Praxis Precision Medicines Vs. Arcutis Biotherapeutics Industry Stock Comparison
Sell
30
PRAX
Praxis Precision Medicines
Last Price:
59.66
Seasonality Move:
-17.58%
Sell
39
ARQT
Arcutis Biotherapeutics
Last Price:
10.39
Seasonality Move:
-24.31%
Sell
30
Praxis Precision Medicines (PRAX)
is a Sell
Is Praxis Precision Medicines a Buy, Sell or Hold?
- The current Praxis Precision Medicines [PRAX] share price is $57.72. The Score for PRAX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- PRAX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Arcutis Biotherapeutics (ARQT)
is a Sell
Is Arcutis Biotherapeutics a Buy, Sell or Hold?
- The current Arcutis Biotherapeutics [ARQT] share price is $10.37. The Score for ARQT is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- ARQT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
PRAX Stock Price Chart
What is Praxis Precision Medicines's stock price today?
-
The Praxis Precision Medicines share price today is $57.72
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRAX is experiencing slight selling pressure.
ARQT Stock Price Chart
What is Arcutis Biotherapeutics's stock price today?
-
The Arcutis Biotherapeutics share price today is $10.37
The current trend is moderately bullish and ARQT is experiencing selling pressure, which indicates risk of future bearish movement.
PRAX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.68 | Buy |
Relative Strength Index (14 RSI): | 54.59 | Buy |
Chaikin Money Flow: | -8706 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (51.48 - 58.2) | Buy |
Bollinger Bands (100): | (43.2 - 56.22) | Buy |
ARQT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.25 | Buy |
Relative Strength Index (14 RSI): | 52.77 | Buy |
Chaikin Money Flow: | -959810 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.07 - 10.91) | Buy |
Bollinger Bands (100): | (8.32 - 10.26) | Buy |
PRAX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 58.12 | Sell |
20-day SMA: | 55.41 | Buy |
50-day SMA: | 54.45 | Buy |
200-day SMA: | 45.13 | Buy |
8-day EMA: | 57.98 | Sell |
20-day EMA: | 56.35 | Buy |
50-day EMA: | 53.66 | Buy |
200-day EMA: | 45.84 | Buy |
ARQT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 10.53 | Sell |
20-day SMA: | 10.23 | Buy |
50-day SMA: | 9.91 | Buy |
200-day SMA: | 8.11 | Buy |
8-day EMA: | 10.46 | Sell |
20-day EMA: | 10.27 | Buy |
50-day EMA: | 9.89 | Buy |
200-day EMA: | 8.94 | Buy |
Praxis Precision Medicines Earnings Growth & PRAX Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.94 per share, a decrease next quarter of $0.36 per share, an increase this year of $11.92 per share, and a decrease next year of $0.31 per share.
Arcutis Biotherapeutics Earnings Growth & ARQT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.17 per share, an increase this year of $2.44 per share, and an increase next year of $0.39 per share.
Praxis Precision Medicines Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Arcutis Biotherapeutics Technical Analysis
Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |